The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Summary of Significant Accounting Policies
Description of Operations and Principles of Consolidation
Cutera, Inc. (“Cutera” or the “Company”) is a global provider of laser and energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, distributes and markets light and energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms:
excel,
enlighten, Juliet, Secret RF, truSculpt
and
xeo
. The Company’s systems offer multiple hand pieces and applications, allowing customers to upgrade their systems. The sales of (i) systems, system upgrades and hand pieces (“Systems” revenue); (ii) hand piece refills applicable to
Titan, truSculpt 3D
and
truSculpt iD
, as well as single use disposable tips applicable to
Juliet
and
Secret RF
(“Consumables” revenue); and (iii) the distribution of third party manufactured skincare products (“Skincare” revenue); are collectively classified as “Products” revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for
Titan, truSculpt 3D
and
truSculpt iD
) and service labor for the repair and maintenance of products that are out of warranty, all of which are classified as “Service” revenue.
Headquartered in Brisbane, California, the Company has wholly-owned subsidiaries that are currently operational in Australia, Belgium, Canada, France, Germany, Hong Kong, Japan, Spain, Switzerland and the United Kingdom. The Company’s wholly owned subsidiary in Italy is currently dormant. These active subsidiaries market, sell and service the Company’s products outside of the United States. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.
Unaudited Interim Financial Information
In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements included in this report reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair statement of its financial position as of March 31, 2019 and 2018, its results of operations, comprehensive loss, consolidated statements of changes in equity, and cash flows for the three months ended March 31, 2019, and 2018. The December 31, 2018 condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The results for interim periods are not necessarily indicative of results for the entire year or any other interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s previously filed audited financial statements and the related notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission (the “SEC”) on March 18, 2019.
Accounting Policies
These unaudited condensed consolidated financial statements are prepared in accordance with the rules and regulations of the SEC applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the financial statement disclosures in our annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 18, 2019.
The Company uses the same accounting policies in preparing quarterly and annual financial statements. Notes 2 and 13 provide information about the Company’s adoption of new accounting standards for leases. Unless otherwise noted, amounts presented within the Notes to Condensed Consolidated Financial Statements refer to the Company’s continuing operations.
Use of Estimates
The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.
On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, accounts receivable and sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, fair value of investments, the standalone selling price of the Company's products and services, the customer life and period of benefit used to capitalize and amortize contracts acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Risks and Uncertainties
The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of world financial markets, cybersecurity breaches and other disruptions that could compromise the Company’s information or results, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, strategic relationships and dependence on key individuals.
Recently Adopted Accounting Pronouncements
In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, "Leases," (also known as ASC Topic 842) which requires, among other items, a lessee to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures were enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. In July 2018, the FASB issued ASU 2018-11, "Targeted Improvements," which gives the option to apply the transition provisions of ASU 2016-02 at its adoption date instead of at the earliest comparative period presented in its financial statements. In addition, ASU 2018-11 provides a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are met. Also in July 2018, the FASB issued ASU 2018-10, "Codification Improvements to ASC Topic 842, Leases," which clarifies certain aspects of ASU 2016-02.
The Company adopted ASU 2016-02, as of January 1, 2019, using the modified retrospective method, to all leases existing at the date of initial application. The comparative period information has not been restated and continues to be reported under the accounting standards in effect for the period presented. The new standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allowed the Company to carry forward the Company’s historical conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient related to land easements, allowing the Company to carry forward the Company’s accounting treatment for land easements on existing agreements. The Company did not elect the practical expedient to use hindsight in determining the lease term.
The adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $10.3 million and $10.4 million, respectively, as of January 1, 2019, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The difference between the additional lease assets and lease liabilities results from rent-free periods which were previously recorded as deferred rent. The Company’s accounting for finance leases remained substantially unchanged. The standard had no material impact on the Company’s condensed consolidated net earnings, results of operations, comprehensive loss, statements of changes in equity, and cash flows.
See Notes 2 and 12 Leases for additional accounting policy and transition disclosures regarding ASC Topic 842.
In June 2018, the FASB issued ASU No. 2018-07, "Compensation-Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting". The new guidance changes the accounting for nonemployee awards including: (1) equity-classified share-based payment awards issued to nonemployees will be measured on the grant date, instead of the previous requirement to remeasure the awards through the performance completion date, (2) for performance conditions, compensation cost associated with the award will be recognized when the achievement of the performance condition is probable, rather than upon achievement of the performance condition, and (3) the current requirement to reassess the classification (equity or liability) for nonemployee awards upon vesting will be eliminated, except for awards in the form of convertible instruments. The new guidance also clarifies that any share-based payment awards issued to customers should be evaluated under ASC Topic 606. The amendments in the new guidance are effective for annual and interim reporting periods beginning after December 15, 2018, with early adoption permitted for public companies, but no earlier than an entity’s adoption date of ASC Topic 606. The Company adopted the new standard effective January 1, 2019. There was no material impact upon adoption of the new standard to the financial statements.
Other Accounting Pronouncements
Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract
In August 2018, the FASB issued ASU No. 2018-15, Intangibles (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service
Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This standard also requires customers to amortize the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The new standard becomes effective for the Company after December 15, 2019 and early adoption is permitted. The Company is planning to early adopt this standard on a prospective basis for applicable implementation costs, and is currently assessing the impact of the adoption of this guidance to its financial statements.
Note 2. Effect of Adoption of the new lease standard (ASC Topic 842) on Condensed consolidated financial statements
The Company adopted ASC Topic 842, Lease, on January 1, 2019, applying the modified retrospective method to all leases existing at the date of initial application. The comparative information has not been adjusted and continues to be reported under the accounting standards in effect for the prior period.
The following table summarizes the effects of adopting Topic 842 on the Company’s condensed consolidated balance sheets as of January 1, 2019 (in thousands):
|
|
As reported under
Topic 842
|
|
|
Adjustments
|
|
|
Balances under
Prior GAAP
|
|
Operating lease right-of-use assets
|
|
$
|
10,049
|
|
|
$
|
10,049
|
|
|
$
|
—
|
|
Operating lease liabilities
|
|
|
(2,430)
|
|
|
|
(2,430)
|
|
|
|
—
|
|
Other long-term liabilities*
|
|
|
—
|
|
|
|
140
|
|
|
|
140
|
|
Operating lease liabilities, net of current portion
|
|
|
(7,759)
|
|
|
|
(7,759)
|
|
|
|
—
|
|
*Deferred rent included in other long-term liabilities
Note 3. Cash, Cash Equivalents and Marketable Investments
The Company invests its cash primarily in money market funds and in highly liquid debt instruments of U.S. federal and municipal governments and their agencies, commercial paper and corporate debt securities. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company’s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover their short term operating expenses.
The Company determines the appropriate classification of its investments in marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. The Company’s marketable securities have been classified and accounted for as available-for-sale securities. Investments with remaining maturities of more than one year are viewed by the Company as available to support current operations and are classified as current assets under the caption marketable investments in the accompanying condensed consolidated balance sheets. Investments in marketable securities are carried at fair value, with the unrealized gains and losses reported as a component of stockholders’ equity. Any realized gains or losses on the sale of marketable securities are determined on a specific identification method, and such gains and losses are reflected as a component of interest and other income, net.
The following tables summarize the components, and the unrealized gains and losses position, related to the Company’s cash, cash equivalents and marketable investments (in thousands):
March 31, 2019
|
|
Amortized
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
Losses
|
|
|
Fair Market
Value
|
|
Cash and cash equivalents
|
|
$
|
19,158
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
19,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government notes
|
|
|
1,405
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,405
|
|
U.S. government agencies
|
|
|
2,694
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,694
|
|
Municipal securities
|
|
|
202
|
|
|
|
—
|
|
|
|
—
|
|
|
|
202
|
|
Commercial paper
|
|
|
2,437
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,437
|
|
Corporate debt securities
|
|
|
1,204
|
|
|
|
—
|
|
|
|
(3
|
)
|
|
|
1,201
|
|
Total marketable investments
|
|
|
7,942
|
|
|
|
—
|
|
|
|
(3
|
)
|
|
|
7,939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable investments
|
|
$
|
27,100
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
27,097
|
|
December 31, 2018
|
|
Amortized
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
Losses
|
|
|
Fair Market
Value
|
|
Cash and cash equivalents
|
|
$
|
26,052
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
26,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government notes
|
|
|
1,397
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,397
|
|
U.S. government agencies
|
|
|
2,677
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,677
|
|
Municipal securities
|
|
|
200
|
|
|
|
—
|
|
|
|
—
|
|
|
|
200
|
|
Commercial paper
|
|
|
2,433
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,433
|
|
Corporate debt securities
|
|
|
2,825
|
|
|
|
—
|
|
|
|
(9
|
)
|
|
|
2,816
|
|
Total marketable investments
|
|
|
9,532
|
|
|
|
—
|
|
|
|
(9
|
)
|
|
|
9,523
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and marketable investments
|
|
$
|
35,584
|
|
|
$
|
—
|
|
|
$
|
(9
|
)
|
|
$
|
35,575
|
|
As of March 31, 2019 and December 31, 2018, the net unrealized losses were $3,000 and $9,000, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months.
The following table summarizes the contractual maturities of the Company’s available-for-sale securities, classified as marketable investments as of March 31, 2019 (in thousands):
|
|
Amount
|
|
Due in less than one year
|
|
$
|
7,939
|
|
Due in 1 to 3 years
|
|
|
—
|
|
Total marketable investments
|
|
$
|
7,939
|
|
Note 4.
Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. The Company’s financial instruments include cash equivalents, marketable investments, accounts receivable, accounts payable and accrued liabilities. Carrying amounts of the Company's financial instruments approximate their fair values as of the balance sheet dates given their generally short maturities. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below in accordance with ASC 820:
● Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
● Level 2: Directly or indirectly observable inputs as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data from actively quoted markets for substantially the full term of the financial instrument.
● Level 3: Unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.
In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.
As of March 31, 2019, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):
March 31,
201
9
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
3,061
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,061
|
|
Commercial paper
|
|
|
—
|
|
|
|
2,693
|
|
|
|
—
|
|
|
|
2,693
|
|
Marketable investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities
|
|
|
—
|
|
|
|
7,939
|
|
|
|
—
|
|
|
|
7,939
|
|
Total assets at fair value
|
|
$
|
3,061
|
|
|
$
|
10,632
|
|
|
$
|
—
|
|
|
$
|
13,693
|
|
As of December 31, 2018, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above was as follows (in thousands):
December 31,
2018
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
3,036
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,036
|
|
Commercial paper
|
|
|
—
|
|
|
|
1,047
|
|
|
|
—
|
|
|
|
1,047
|
|
Marketable investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities
|
|
|
—
|
|
|
|
9,523
|
|
|
|
—
|
|
|
|
9,523
|
|
Total assets at fair value
|
|
$
|
3,036
|
|
|
$
|
10,570
|
|
|
$
|
—
|
|
|
$
|
13,606
|
|
The Company’s Level 1 financial assets are money market funds with fair values that are based on quoted market prices. The Company’s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The average remaining maturity of the Company’s Level 2 investments as of March 31, 2019 is less than 7 months and all of these investments are rated by S&P and Moody’s at A or better. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the quarter and year ended March 31, 2019 and December 31, 2018, respectively.
Note 5.
Balance Sheet Details
Inventories
As of March 31, 2019 and December 31, 2018, inventories consist of the following (in thousands):
|
|
March
31,
201
9
|
|
|
December 31,
2018
|
|
Raw materials
|
|
$
|
16,864
|
|
|
$
|
16,991
|
|
Work in process
|
|
|
1,325
|
|
|
|
2,306
|
|
Finished goods
|
|
|
8,470
|
|
|
|
8,717
|
|
Total
|
|
$
|
26,659
|
|
|
$
|
28,014
|
|
Accrued Liabilities
As of March 31, 2019 and December 31, 2018, accrued liabilities consist of the following (in thousands):
|
|
March 31,
2019
|
|
|
December 31,
2018
|
|
Accrued payroll and related expenses
|
|
$
|
8,892
|
|
|
$
|
9,377
|
|
Sales and marketing accruals
|
|
|
2,089
|
|
|
|
2,379
|
|
Warranty liability
|
|
|
4,064
|
|
|
|
4,666
|
|
Sales tax
|
|
|
2,970
|
|
|
|
2,935
|
|
Other
|
|
|
3,773
|
|
|
|
3,943
|
|
Total
|
|
$
|
21,788
|
|
|
$
|
23,300
|
|
Product Remediation Liability
During the fourth quarter of 2018, the Company recognized a liability for a product remediation plan related to one of its legacy systems. This was related to a voluntary action initiated by the Company to replace a component in one of the Company’s legacy products. The remediation plan consists primarily of replacement of a component in the system. The accrued liability consisted of cost of materials and labor to replace the component in all units that are under the Company's standard warranty or are covered under the existing extended warranty contracts. The Company recorded approximately $5.0 million related to this remediation, of which $1.1 million was utilized in the fourth quarter of 2018. Approximately $0.7 million of the remaining unutilized balance was related to product warranty and included in accrued liabilities and $3.2 million was separately recorded as Extended warranty liability.
In the three months ended March 31, 2019, the Company utilized $0.1 million related to product warranty and $0.5 million related to extended warranty liability. As of March 31, 2019, product warranty and extended warranty liability were $0.6 million and $2.7 million, respectively.
Note 6. Warranty and
Extended
Service Contract
The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Belgium, France, Germany, Hong Kong, Japan, Spain and Switzerland, as well as through third-party service providers in the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.
After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides for the estimated cost to repair or replace products under standard warranty at the time of sale. Costs incurred in connection with extended service contracts are recognized at the time when costs are incurred, except the one-time extended service contracts charge of $3.2 million in December 31, 2018, related to the cost to replace a component in one of the Company's legacy products.
The following table provides the changes in the product standard warranty accrual for the three months ended March 31, 2019 and 2018 (in thousands):
|
|
Three Months Ended
|
|
|
|
March
3
1
,
|
|
|
|
2019
|
|
|
2018
|
|
Beginning Balance
|
|
$
|
4,668
|
|
|
$
|
3,508
|
|
Add: Accruals for warranties issued during the period
|
|
|
1,444
|
|
|
|
2,264
|
|
Less: Settlements made during the period
|
|
|
(2,048)
|
|
|
|
(2,399)
|
|
Ending Balance
|
|
$
|
4,064
|
|
|
$
|
3,373
|
|
The $2.0 million settlements as of March 31, 2019 exclude cost related to extended service contract cost of $0.5 million to replace a component in one of the Company's legacy products (See Note 5).
Note 7. Deferred Revenue
The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company’s extended service contracts typically have one, two or three year terms. Deferred revenue also includes payments for installation, training and extended marketing support service. Approximately 78% of the Company’s deferred revenue balance of $13.1 million as of March 31, 2019 will be recognized over the next 12 months.
The following table provides changes in the deferred service contract revenue balance for the three months ended March 31, 2019 and 2018 (in thousands):
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Beginning Balance
|
|
$
|
11,855
|
|
|
$
|
10,719
|
|
Add: Payments received
|
|
|
4,142
|
|
|
|
2,995
|
|
Less: Revenue recognized
|
|
|
(3,522)
|
|
|
|
(3,347)
|
|
Ending Balance
|
|
$
|
12,475
|
|
|
$
|
10,367
|
|
Costs for extended service contracts were $2.0 million and $1.9 million, for the three months ended March 31, 2019 and 2018, respectively.
Note
8
. Revenue
Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company’s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 15% and 14% of the Company’s total revenue for the three months ended March 31, 2019 and 2018, respectively.
The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company’s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company’s promise to transfer the products or service to the customer is separately identifiable from other promises in the contract. The Company’s system sale arrangements include a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts and marketing services.
For the Company’s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company’s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), training, time and materials services are also sold on a stand-alone basis, and related performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.
Nature of Products and Services
Systems
System revenue represents the sale of a system or an upgrade of an existing system. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy based module, control system software and high voltage electronics, as well as one or more hand pieces. However, depending on the application, the laser or other energy based module is sometimes contained in the hand piece such as with the Company’s
Pearl
and
Pearl Fractional
applications instead of within the console.
The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.
The Company concludes that the system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.
The Company does not identify calibration and installation services for systems other than
enlighten
as performance obligations because such services are immaterial in the context of the contract. The related costs to complete calibration and installation for systems other than
enlighten
are immaterial. Calibration and installation services for
enlighten
systems are identified as separate performance obligations.
For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. The Company recognizes revenue on cash basis for system sales to international direct end-customers that have not been credit approved, when the performance obligations in the contract are satisfied. For systems sold through credit approved distributors, revenue is recognized at the time of shipment.
The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.
Skincare products
The Company sells third-party manufactured skincare products in Japan. The third-party skincare products are purchased from the third-party manufacturers and sold to licensed physicians. The Company acts as the principal in this arrangement, as it determines the price to charge customers for the skincare products, and controls the products before they are transferred to the customer. Skincare products are typically sold in contracts in which the skincare products represent the sole performance obligations. The Company recognizes revenue for skincare products at a point in time, upon shipment.
Consumables (Other accessories)
The Company treats its customers' purchases of replacement
Titan
,
truSculpt 3D
and
truSculpt iD
hand pieces as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The
Juliet
and
Secret RF
products have single use disposable tips which must be replaced after every treatment. Sales of these consumable tips further enhance the Company’s recurring revenue. Hand piece refills of the Company’s legacy
truSculpt
product are accounted for in accordance with the Company’s standard warranty and service contract policies.
Extended contract services
The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of one, two, or three years. Service contract revenue is recognized over time, using a time based measure of progress, as the customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements, parts and labor. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company’s installed product base.
Training
Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer’s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.
Customer Marketing Support
In North America, the Company offers marketing and consulting phone support to its customers across all system platforms. These customer marketing support services include a practice development model and marketing training, performed remotely with ongoing phone consultations for six months from date of purchase. The Company considers customer marketing support a separate performance obligation, and recognizes revenue over the six-month term of the contracts.
Significant Judgments
The Company combines two or more contracts entered into at or near the same time with the same customer and accounts for the contracts as a single contract. The contracts are negotiated as a package with a single commercial objective. The Company exercises significant judgment to determine whether each separate contract in the combined contracts contains distinct performance obligations, which could have an effect on results of operations for the periods involved.
The Company is required to estimate the total consideration expected to be received from contracts with customers. In limited circumstances, the consideration expected to be received is variable based on the specific terms of the contract. The Company has not experienced significant returns or refunds to customers. Estimating consideration expected to be received from contracts with customers requires significant judgment and the change in these estimates could have an effect on its results of operations during the periods involved.
The Company determines standalone selling price ("SSP") for each performance obligation as follows:
●
|
Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers. When SSP is not directly observable, the Company estimates SSP using the expected cost plus margin approach.
|
●
|
Training: SSP is based on observable price when sold on a standalone basis.
|
●
|
Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis (by customer type).
|
●
|
Customer Marketing Support: SSP is estimated based on cost plus a margin.
|
●
|
Set-up /Installation: Set-up or installation for all other systems, excluding the
enlighten
system, is immaterial in the context of the contract. The related costs to complete set-up or installation are immaterial.
|
The calibration and installation service of the
enlighten
system are treated as separate performance obligations because the Company regularly sells
enlighten
systems without the calibration and installation service.
Loyalty Program
The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the programs, customers accumulate points based on their purchasing levels. Once a loyalty program member achieves a certain tier level, the member earns a reward. A customer’s account has to be in good standing in order to receive the benefits of the rewards program. Rewards are given on a quarterly basis and must be used in the following quarter. Customers receive a notification regarding their rewards tier by the fifth (5th) day of the following quarter. All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction of net revenue at the time the reward is earned.
Deferred Sales Commissions
Incremental costs of obtaining a contract, including sales commissions, are capitalized and amortized on a straight-line basis over the expected customer relationship period. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally two to three years.
Total net capitalized costs as of March 31, 2019 were $5.1 million and are included in other assets in the Company’s condensed consolidated balance sheet. Amortization of these assets was $0.7 million during the three months ended March 31, 2019 and is included in sales and marketing expense in the Company’s condensed consolidated statement of operations.
Note 9. Stockholders’ Equity and Stock-based Compensation Expense
As of March 31, 2019, the Company had the following stock-based employee compensation plans:
2004 Equity Incentive Plan and 1998 Stock Plan
In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which 4,650,000 shares of the Company’s common stock were reserved for issuance to employees, directors and consultants. On January 12, 2004, the Board of Directors adopted the 2004 Equity Incentive Plan, or 2004 Plan. A total of 1,750,000 shares of common stock were originally reserved for issuance pursuant to the 2004 Plan. In addition, the shares reserved for issuance under the 2004 Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012, the stockholders approved a “fungible share” provision whereby each full-value award issued under the 2004 Plan results in a requirement to subtract 2.12 shares from the shares reserved under the 2004 Plan.
Options granted under the 1998 Plan and 2004 Plan may be incentive stock options or non-statutory stock options. Stock purchase rights may also be granted under the 2004 Plan. Incentive stock options may only be granted to employees. The Board of Directors determines the period over which options become exercisable. Options granted under the 2004 Plan to employees generally vest over a four-year term from the vesting commencement date and become exercisable 25% on the first anniversary of the vesting commencement date and an additional 1/48th monthly anniversary date until all of the shares have become exercisable.
The Company issued 19,892 Restricted Stock Units (“RSUs”) to its non-employee directors during the quarter ended March 31, 2019. The Company’s Board of Directors granted its executive officers, senior management and certain employees 307,355 Performance Stock Units (“PSUs”) during the quarter ended March 31, 2019. The PSUs granted in quarter ended March 31, 2019 vest subject to the recipients continued service and to the achievement of certain operational goals for the Company’s 2019 fiscal year which consist of the achievement of revenue targets for consumable products, implementation of the new enterprise resource planning (“ERP”) system for North America and the achievement of specific product milestones.
The Company’s Board of Directors also granted its executive officers, senior management and certain employees 245,782 RSUs during the quarter ended March 31, 2019. The annual RSUs granted vest over four years at 25% on each anniversary of the grant date.
Under the 2004 Plan, as amended, the Company issued 66,523 shares of common stock during the three months ended March 31, 2019, in conjunction with stock options exercised and the vesting of RSUs and PSUs.
As of March 31, 2019, there was approximately $14.9 million of unrecognized compensation expense, net of projected forfeitures, for stock options and stock awards. The expense is expected to be recognized over the remaining weighted-average period of 1.9 years. The actual expense recorded in the future may be higher or lower based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.
Activity under the 1998 and 2004 Plans are summarized as follows:
|
|
|
|
|
|
Options Outstanding
|
|
|
|
Shares
Available
for Grant
|
|
|
Number of
Stock Options
Outstanding
|
|
|
Weighted-
Average Exercise
Price
|
|
Balance, December 31,
2018
|
|
|
1,141,305
|
|
|
|
507,705
|
|
|
$
|
20.52
|
|
Stock awards granted*
|
|
|
(1,259,808)
|
|
|
|
—
|
|
|
|
—
|
|
Options exercised
|
|
|
—
|
|
|
|
(16,644)
|
|
|
|
7.87
|
|
Options canceled
|
|
|
22,198
|
|
|
|
(22,198)
|
|
|
|
21.19
|
|
Stock awards canceled*
|
|
|
265,261
|
|
|
|
—
|
|
|
|
—
|
|
Balance, March 31,
2019
|
|
|
168,956
|
|
|
|
468,863
|
|
|
$
|
20.94
|
|
*
The Company has a “fungible share” provisi
on in its 2004
Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan requires the subtraction or add back of 2.12 shares from or to the Shares Available for Grant, respectively. In the Company’s 2019 Proxy Statement, filed on April 30, 2019, the Company is seeking stockholder approval to remove the “fungible share” provision for awards granted on or after June 14, 2019.
Non-Employee Stock-Based Compensation
The Company granted 9,303 RSUs and 11,920 PSUs to non-employees during the quarter ended March 31, 2019, and 3,384 RSUs during the year ended December 31, 2018. The PSUs granted to non-employee vest over a year subject to same performance criteria as employees. The PSUs granted in quarter ended March 31, 2019 vest subject to the recipients continued service and to the achievement of certain operational goals for the Company’s 2019 fiscal year which consist of the achievement of revenue targets for international system revenue, implementation of the new ERP system for North America and the achievement of specific product milestones.
Stock-based Compensation Expense
Stock-based compensation expense by department recognized during the three months ended March 31, 2019 and 2018 were as follows (in thousands):
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Cost of revenue
|
|
$
|
269
|
|
|
$
|
154
|
|
Sales and marketing
|
|
|
718
|
|
|
|
489
|
|
Research and development
|
|
|
263
|
|
|
|
191
|
|
General and administrative
|
|
|
57
|
|
|
|
854
|
|
Total stock-based compensation expense*
|
|
$
|
1,307
|
|
|
$
|
1,688
|
|
*Included in the stock-based compensation expense is the charge in connection with the accelerated vesting of 4,667 shares of the Company’s former CEO, in accordance with his separation agreement dated January 4, 2019.
Note
10
. Net Loss Per Share
Basic net income (loss) per share is computed using the weighted-average number of shares outstanding during the period. In periods of net income, diluted shares outstanding include the dilutive effect of in-the-money equity awards (stock options, restricted stock units, performance stock units and employee stock purchase plan contributions), which is calculated based on the average share price for each fiscal period using the treasury stock method.
Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.
The following table sets forth the computation of basic and diluted net income (loss) and the weighted average number of shares used in computing basic and diluted net income (loss) per share (in thousands, except per share data):
|
|
Three Months Ended
March 31, 2019
|
|
|
Three Months Ended
March 31, 2018
|
|
Numerator:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(8,220)
|
|
|
$
|
(2,032)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic
|
|
|
14,017
|
|
|
|
13,587
|
|
Dilutive effect of incremental shares and share equivalents
|
|
|
—
|
|
|
|
—
|
|
Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted
|
|
|
14,017
|
|
|
|
13,587
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
Net income (loss) per share, basic and diluted
|
|
$
|
(0.59)
|
|
|
$
|
(0.15)
|
|
The following numbers of shares outstanding, prior to the application of the treasury stock method, were excluded from the computation of diluted net income (loss) per common share for the period presented because including them would have had an anti-dilutive effect (in thousands):
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Options to purchase common stock
|
|
|
485
|
|
|
|
807
|
|
Restricted stock units
|
|
|
366
|
|
|
|
396
|
|
Performance stock units
|
|
|
21
|
|
|
|
23
|
|
Employee stock purchase plan shares
|
|
|
66
|
|
|
|
34
|
|
Total
|
|
|
938
|
|
|
|
1,260
|
|
N
ote 11
. Income Taxes
The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to ordinary income or loss for the interim reporting period. When applicable, the year-to-date tax provision reflects adjustments from discrete tax items.
The Company's income tax expense for the three months ended March 31, 2019 relates primarily to income taxes of the Company's non-U.S. operations based on the annual effective tax rate method. The Company's U.S. operations continue to be in a loss position and the Company maintains a 100% valuation allowance against its U.S. deferred tax assets.
For the three months ended March 31, 2019, the Company's income tax expense was $115,000 compared to a tax benefit of $2.6 million for the same period in 2018. The income tax benefit for the three months ended March 31, 2018 includes a tax benefit for excess tax deductions of approximately $1.5 million, recorded discretely in the reporting period.
The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. As of March 31, 2019, and December 31, 2018, the Company had a 100% valuation allowance against its U.S. deferred tax assets. There was no valuation allowance during the three months ended March 31, 2018 other than the California jurisdiction.
Significant management judgment is required in determining any valuation allowance recorded against deferred tax assets. In evaluating the ability to recover deferred tax assets, the Company considered available positive and negative evidence giving greater weight to its recent cumulative losses and lesser weight to its projected financial results due to the subjectivity involved in forecasting future periods. The Company also considered, commensurate with its objective verifiability, the forecast of future taxable income including the reversal of temporary differences and the implementation of feasible and prudent tax planning strategies.
Note 12. Leases
The Company has operating and finance leases for vehicles, office space and storages. The Company’s material operating leases consist of office space, as well as storage facilities. The Company’s leases generally have remaining terms of 1 to 10 years, some of which include options to renew the leases for up to 5 years. The Company leases space for operations in the United States, Japan and France. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under operating leases.
The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.
The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.
Supplemental balance sheet information related to leases was as follows:
Leases
(in thousands)
|
Classification
|
|
March 31, 2019
|
|
Assets
|
|
|
|
|
|
Right-of-use assets
|
Operating lease assets
|
|
$
|
9,442
|
|
Finance lease
|
Property and equipment, net
*
|
|
|
842
|
|
Total leased assets
|
|
$
|
10,284
|
|
*Finance leases assets included in Property and equipment, net.
|
Liabilities
|
|
|
|
|
|
Operating lease liabilities
|
|
|
|
|
|
Operating lease liabilities, current
|
Operating lease liabilities
|
|
|
1,840
|
|
Operating lease liabilities , non-current
|
Operating lease liabilities, net of current portion
|
|
|
7,759
|
|
Total Operating lease liabilities
|
|
|
$
|
9,599
|
|
|
|
|
|
|
|
Finance lease liabilities
|
|
|
|
|
|
Finance lease liabilities, current
|
Accrued liabilities
*
|
|
|
614
|
|
Finance lease liabilities, non-current
|
Operating lease liabilities
|
|
|
354
|
|
Total Finance lease liabilities
|
|
$
|
968
|
|
* Finance lease liabilities included in Accrued liabilities
Lease cost as of March 31, 2019 were as follows:
Finance lease cost: Total amortization expense and interest for finance lease during the three months ended March 31, 2019 were $183 and $19, respectively.
Operating lease cost: Total operating lease expense during the three months ended March 31, 2019 was $724.
Cash paid for amounts included in the measurement of lease liabilities during the three months ended March 31, 2019 were as follows:
Operating cash flow from finance leases for the three months was $19.
Financing cash flow from finance leases for the three months was $131.
Operating cash flow from operating leases for the three months was $705.
Maturities of lease liabilities
Maturities of lease liabilities were as follows as of March 31, 2019 (in thousands):
Year Ending March 31,
|
|
Amount
|
|
Remainder of 2019
|
|
$
|
2,113
|
|
2020
|
|
|
2,852
|
|
2021
|
|
|
2,591
|
|
2022
|
|
|
2,559
|
|
2023 and thereafter
|
|
|
282
|
|
Total lease payments
|
|
|
10,397
|
|
Less: imputed interest
|
|
|
798
|
|
Present value of lease liabilities
|
|
$
|
9,599
|
|
Vehicle Leases
As of March 31, 2019, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable capital leases as follows (in thousands):
Year Ending March 31,
|
|
Amount
|
|
Remainder of 2019
|
|
$
|
573
|
|
2020
|
|
|
296
|
|
2021
|
|
|
161
|
|
2021
|
|
|
7
|
|
Total lease payments
|
|
|
1,037
|
|
Less: imputed interest
|
|
|
69
|
|
Present value of lease liabilities
|
|
$
|
968
|
|
As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, maturities of lease liabilities were as follows as of December 31, 2018:
Facility Leases
As of December 31, 2018, the Company was committed to minimum lease payments for facilities and other leased assets under long-term non-cancelable operating leases as follows (in thousands):
Year Ending December 31,
|
|
Amount
|
|
2019
|
|
$
|
3,011
|
|
2020
|
|
|
2,939
|
|
2021
|
|
|
2,564
|
|
2022
|
|
|
2,495
|
|
2023 and thereafter
|
|
|
214
|
|
Future minimum rental payments
|
|
$
|
11,223
|
|
Vehicle Leases - US
As of December 31, 2018, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable capital leases as follows (in thousands):
Year Ending December 31,
|
|
Amount
|
|
2019
|
|
$
|
576
|
|
2020
|
|
|
287
|
|
2021
|
|
|
152
|
|
Future minimum lease payments
|
|
$
|
1,015
|
|
Weighted-average remaining lease term and discount rate, as of March 31, 2019, were as follows:
Lease Term and Discount Rate
|
|
March 31, 2019
|
|
Weighted-average remaining lease term (years)
|
|
|
|
|
Operating leases
|
|
|
3.7
|
|
Finance leases
|
|
|
3.0
|
|
Weighted-average discount rate
|
|
|
|
|
Operating leases
|
|
|
4.4
|
%
|
Finance leases
|
|
|
5.6
|
%
|
Note 13. Contingencies
The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company’s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.
As of March 31, 2019 and December 31, 2018, the Company had accrued Nil and $171,000 respectively, related to various pending contractual and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.
Note 14
. Debt
On May 30, 2018, the Company and Wells Fargo Bank, N.A. (“Wells Fargo”) entered into a Loan and Security Agreement (the “Original Revolving Line of Credit”) in the original principal amount of $25 million. The Original Revolving Line of Credit terminates on May 30, 2021.
On or about November 2, 2018, the Company entered into a First Amendment and Waiver to the Loan and Security Agreement with Wells Fargo (the “First Amended Revolving Line of Credit”). The First Amended Revolving Line of Credit provided for an original principal amount of $15 million, with the ability to request an additional $10 million, and a waiver of any existing defaults under the Original Revolving Line of Credit as long as the Company is in compliance with the terms of the First Amended Revolving Line of Credit.
On or about, March 11, 2019, the Company entered into a Second Amendment and Waiver to the Loan and Security Agreement with Wells Fargo (the “Second Amended Revolving Line of Credit”). The Second Amended Revolving Line of Credit requires the Company to maintain a minimum cash balance of $15 million at Wells Fargo, but removes all other covenants so long as no money is drawn on the line of credit. The Company may draw down on the line of credit at the time it reaches and maintains trailing twelve months ("TTM") adjusted EBITDA of not less than $10 million, and a leverage ratio not to exceed 2.5 to 1.0.
As of March 31, 2019, the Company had not drawn on the Revolving Line of Credit and the Company is in compliance with all financial covenants of the Original Revolving Line of Credit, as amended by the First Amended Revolving Line of Credit and the Second Amended Revolving Line of Credit.
Note 15
. Segment reporting
Segment reporting is based on the “management approach,” following the method that management organizes the company’s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company’s chief operating decision maker ("CODM") is its Chief Executive Officer ("CEO"), who makes decisions on allocating resources and in assessing performance. The CEO reviews the Company's consolidated results as one operating segment. In making operating decisions, the CEO primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company’s principal operations and decision-making functions are located in the U.S. The Company’s CEO views its operations, manages its business, and uses one measurement of profitability for the one operating segment - which sells aesthetic medical equipment and services, and distributes skincare products, to qualified medical practitioners. Substantially all of the Company’s long-lived assets are located in the U.S.
The following table presents a summary of revenue by geography for the three months March 31 2019 and 2018 (in thousands):
|
|
Three Months Ended
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Revenue mix by geography:
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
20,400
|
|
|
$
|
21,136
|
|
Japan
|
|
|
5,294
|
|
|
|
3,555
|
|
Asia, excluding Japan
|
|
|
3,095
|
|
|
|
2,843
|
|
Europe
|
|
|
2,736
|
|
|
|
2,570
|
|
Rest of the world
|
|
|
4,501
|
|
|
|
4,021
|
|
Total consolidated revenue
|
|
$
|
36,026
|
|
|
$
|
34,125
|
|
Revenue mix by product category:
|
|
|
|
|
|
|
|
|
Products
|
|
$
|
27,209
|
|
|
$
|
27,239
|
|
Consumables
|
|
|
1,945
|
|
|
|
769
|
|
Skincare
|
|
|
1,608
|
|
|
|
1,256
|
|
Total product revenue
|
|
$
|
30,762
|
|
|
$
|
29,264
|
|
Service
|
|
|
5,264
|
|
|
|
4,861
|
|
Total consolidated revenue
|
|
$
|
36,026
|
|
|
$
|
34,125
|
|